🔎 Trials Near Me

Beranda › Kanker Darah › Washington › Seattle

Uji klinis Kanker Darah di Seattle, WA

18 studi untuk Kanker Darah mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • dan 1 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Menerima pesertaFase 1/2
  • Fred Hutchinson Cancer Research Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06697184

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Menerima pesertaFase 3
  • Fred Hutchinson Cancer Research Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Menerima pesertaStudi observasional
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Menerima pesertaFase 1
  • University of Washington, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Menerima pesertaSukarelawan sehat diterima
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04515810

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Menerima pesertaFase 2
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06665100

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Fred Hutchinson Cancer Research Center, Seattle
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

Menerima pesertaFase 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05952804

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Menerima pesertaFase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT03670966

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Menerima pesertaStudi observasional
  • Seattle Childrens Hospital, Seattle
Hingga usia 30 · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT06579469

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Menerima pesertaFase 1/2
  • University of Washington Medical Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Menerima pesertaFase 2Sukarelawan sehat diterima
  • Fred Hutchinson Cancer Centre, Seattle
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT06510699

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Menerima pesertaStudi observasional
  • Swedish Cancer Institute, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2025 · NCT05768269

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

Menerima peserta
  • University of Washington, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2025 · NCT05956457

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Menerima pesertaFase 1
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Menerima pesertaFase 1
  • Seattle Children's Hospital, Seattle
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Menerima pesertaFase 1
  • Fred Hutchinson Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Nov 2024 · NCT06034275

Uji klinis Kanker Darah di kota lain

Studi lain di Seattle

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.